A citation-based method for searching scientific literature


List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
172
100

Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.
Kandamurugu Manickam, Adam H Buchanan, Marci L B Schwartz, Miranda L G Hallquist, Janet L Williams, Alanna Kulchak Rahm, Heather Rocha, Juliann M Savatt, Alyson E Evans, Loren M Butry,[...]. JAMA Netw Open 2018
75
100

Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls.
Yukihide Momozawa, Yusuke Iwasaki, Michael T Parsons, Yoichiro Kamatani, Atsushi Takahashi, Chieko Tamura, Toyomasa Katagiri, Teruhiko Yoshida, Seigo Nakamura, Kokichi Sugano,[...]. Nat Commun 2018
51
100

Population and breast cancer patients' analysis reveals the diversity of genomic variation of the BRCA genes in the Mexican population.
J C Fernández-Lopez, S Romero-Córdoba, R Rebollar-Vega, L A Alfaro-Ruiz, S Jiménez-Morales, F Beltrán-Anaya, R Arellano-Llamas, A Cedro-Tanda, M Rios-Romero, M Ramirez-Florencio,[...]. Hum Genomics 2019
9
100

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Efrat Gabai-Kapara, Amnon Lahad, Bella Kaufman, Eitan Friedman, Shlomo Segev, Paul Renbaum, Rachel Beeri, Moran Gal, Julia Grinshpun-Cohen, Karen Djemal,[...]. Proc Natl Acad Sci U S A 2014
191
100

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.
Noura S Abul-Husn, Emily R Soper, Jacqueline A Odgis, Sinead Cullina, Dean Bobo, Arden Moscati, Jessica E Rodriguez, Ruth J F Loos, Judy H Cho, Gillian M Belbin,[...]. Genome Med 2019
21
50

Germline variation in BRCA1/2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients.
Shanmuga Priya Bhaskaran, Khyati Chandratre, Hemant Gupta, Li Zhang, Xiaoyu Wang, Jian Cui, Yeong C Kim, Siddharth Sinha, Luhan Jiang, Boya Lu,[...]. Int J Cancer 2019
21
50



Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Ranjit Manchanda, Shreeya Patel, Vladimir S Gordeev, Antonis C Antoniou, Shantel Smith, Andrew Lee, John L Hopper, Robert J MacInnis, Clare Turnbull, Susan J Ramus,[...]. J Natl Cancer Inst 2018
73
50

Large-Scale Whole-Genome Sequencing of Three Diverse Asian Populations in Singapore.
Degang Wu, Jinzhuang Dou, Xiaoran Chai, Claire Bellis, Andreas Wilm, Chih Chuan Shih, Wendy Wei Jia Soon, Nicolas Bertin, Clarabelle Bitong Lin, Chiea Chuen Khor,[...]. Cell 2019
24
50

Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia.
Wei Xiong Wen, Jamie Allen, Kah Nyin Lai, Shivaani Mariapun, Siti Norhidayu Hasan, Pei Sze Ng, Daphne Shin-Chi Lee, Sheau Yee Lee, Sook-Yee Yoon, Joanna Lim,[...]. J Med Genet 2018
17
50

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients.
Holly LaDuca, Eric C Polley, Amal Yussuf, Lily Hoang, Stephanie Gutierrez, Steven N Hart, Siddhartha Yadav, Chunling Hu, Jie Na, David E Goldgar,[...]. Genet Med 2020
53
50

Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer.
Karin Kast, Kerstin Rhiem, Barbara Wappenschmidt, Eric Hahnen, Jan Hauke, Britta Bluemcke, Verena Zarghooni, Natalie Herold, Nina Ditsch, Marion Kiechle,[...]. J Med Genet 2016
75
50

Prevalence of BRCA1/BRCA2 pathogenic variation in Chinese Han population.
Hui Dong, Khyati Chandratre, Yue Qin, Jing Zhang, Xiaoqing Tian, Ce Rong, Ning Wang, Maoni Guo, Guoping Zhao, San Ming Wang. J Med Genet 2021
3
50

Population Frequency of Germline BRCA1/2 Mutations.
Kara N Maxwell, Susan M Domchek, Katherine L Nathanson, Mark E Robson. J Clin Oncol 2016
51
50

Genetics and genomic medicine in Israel.
Joël Zlotogora. Mol Genet Genomic Med 2014
31
50

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
50

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
50

Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.
Kelly A Metcalfe, Aletta Poll, Robert Royer, Marcia Llacuachaqui, Anna Tulman, Ping Sun, Steven A Narod. J Clin Oncol 2010
109
50

BRCA1 and BRCA2: different roles in a common pathway of genome protection.
Rohini Roy, Jarin Chun, Simon N Powell. Nat Rev Cancer 2011
681
50

Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.
Ava Kwong, Enders Kai On Ng, Chris Lei Po Wong, Fian Bic Fai Law, Tommy Au, Hong Nei Wong, Allison W Kurian, Dee W West, James M Ford, Edmond Siu Kwan Ma. PLoS One 2012
57
50

Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer.
Y K Lim, P T C Lau, A B Ali, S C Lee, J E-L Wong, T C Putti, J-H Sng. Clin Genet 2007
43
50

Is it time to offer BRCA1 and BRCA2 testing to all Jewish women?
K A Metcalfe, A Eisen, J Lerner-Ellis, S A Narod. Curr Oncol 2015
12
50

Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women.
Shreeya Patel, Rosa Legood, D Gareth Evans, Clare Turnbull, Antonis C Antoniou, Usha Menon, Ian Jacobs, Ranjit Manchanda. Am J Obstet Gynecol 2018
16
50

Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots".
Jennifer N Dines, Brian H Shirts, Thomas P Slavin, Tom Walsh, Mary-Claire King, Douglas M Fowler, Colin C Pritchard. Genet Med 2020
7
50

Targeting DNA Repair in Cancer: Beyond PARP Inhibitors.
Jessica S Brown, Brent O'Carrigan, Stephen P Jackson, Timothy A Yap. Cancer Discov 2017
238
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.